Home  >  Products  >  ACVR2B (activin A receptor, type IIB) Blocking Peptide (the middle region of ACVR2B)(100ug)
ACVR2B (activin A receptor, type IIB) Blocking Peptide (the middle region of ACVR2B)(100ug)

ACVR2B (activin A receptor, type IIB) Blocking Peptide (the middle region of ACVR2B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ACVR2B Antibody(ARP45042_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP45042
Size: 100ug
Weight: 58kDa
Gene: 93
Format: Lyophilized powder
Target: Activin receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. ACVR2B is activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor.
Alternative names: ACTRIIB; ActR-IIB; MGC116908
See Full Product Listings >